ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
리시노프릴 시장 규모는 향후 몇 년 동안 강력한 성장이 예상됩니다. 2029년에는 CAGR 5.9%로 23억 5,000만 달러로 성장할 것입니다. 예측 기간의 성장은 고혈압 및 심혈관질환의 유병률 증가, 제네릭 의약품과 비용 효율성, 인식 제고 및 조기 진단, 효과적인 치료에 대한 수요 증가, 고령화 등에 기인하는 것으로 보입니다. 예측 기간의 주요 동향으로는 약물전달의 혁신, 환자 중심의 약물전달 접근법 강화의 필요성, 비용 효율적인 솔루션에 대한 수요, 심부전에 대한 효과적인 치료법에 대한 수요, 당뇨병성 신장 질환에 대한 효과적인 치료법에 대한 수요 등을 꼽았습니다.
향후 5년간 5.9%의 성장률 전망은 지난번 예측보다 0.4% 소폭 하락한 수치입니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향에 기인합니다. 관세 인상은 인도와 푸에르토리코에서 조달하는 안지오텐신 전환 효소(ACE) 억제제 및 품질 관리 검사 장비의 비용을 상승시켜 고혈압 치료 비용을 악화시키고 의약품 접근성 격차를 발생시켜 미국 의료 시스템에 부담을 줄 가능성이 높습니다. 또한, 상호 관세와 무역 긴장과 제한의 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향은 더욱 광범위하게 나타날 것으로 보입니다.
심혈관질환의 유병률 증가는 향후 리시노프릴 시장의 성장을 견인할 것으로 예상됩니다. 심혈관질환(CVD)은 심장과 혈관에 영향을 미치는 다양한 질환을 말합니다. 이러한 질병의 발병률 증가는 인구 증가, 고령화, 위험 요인, 효과적인 예방 및 치료 전략의 불충분한 실행 등의 요인에 기인합니다. 리시노프릴은 주로 혈압을 낮추고 심장과 신장의 부담을 줄여 심혈관질환 관리에 도움을 줍니다. 안지오텐신II의 생성을 억제하고, 혈관 확장을 촉진하며, 혈액량을 감소시키고, 장기를 손상으로부터 보호하여 효과를 발휘합니다. 예를 들어, 싱가포르에 본부를 둔 비영리 단체인 싱가포르 심장재단(SHF)은 2024년 5월 허혈성 심장질환으로 인한 사망자 수가 5,302명으로 2022년 5,290명보다 약간 증가했다고 보고했습니다. 따라서 심혈관질환의 유병률 증가는 리시노프릴 시장의 성장을 촉진하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 리시노프릴 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업 분석
세계의 리시노프릴 시장 : 성장률 분석
세계의 리시노프릴 시장 실적 : 규모와 성장, 2019-2024
세계의 리시노프릴 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계의 리시노프릴 : 총 잠재 시장 규모(TAM)
제6장 시장 세분화
세계의 리시노프릴 시장 브랜드별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제스트레틱
푸린 빌딩
제스트릴
기타 브랜드
세계의 리시노프릴 시장 : 질환별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
고혈압
심부전
심장 발작
스트로크
당뇨병성 신장병
기타 질병
세계의 리시노프릴 시장 투여량별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
태블릿
액체
기타 투여량
세계의 리시노프릴 시장 인구 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
아동
성인
세계의 리시노프릴 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
병원
전문 클리닉
기타 최종사용자
세계의 리시노프릴 시장 : 하위 세분화 제스트레틱, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
다른 제형
제스트레틱 제네릭 의약품
세계의 리시노프릴 시장 : 하위 세분화 푸린 빌딩, 종류별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
다른 제형
푸린 빌딩 제네릭 의약품
세계의 리시노프릴 시장 : 하위 세분화 제스트릴, 종류별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
다른 제형
제스트릴 제네릭 의약품
세계의 리시노프릴 시장 : 하위 세분화 기타 브랜드(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
국제 브랜드 베리에이션
복합 의약품 제제
제7장 지역별·국가별 분석
세계의 리시노프릴 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세계의 리시노프릴 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
리시노프릴 시장 : 경쟁 구도
리시노프릴 시장 : 기업 개요
Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
AstraZeneca Plc Overview, Products and Services, Strategy and Financial Analysis
Vitaris Inc. Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업과 혁신적 기업
Teva Pharmaceutical Industries Limited
Bausch Health Companies Inc.
Hetero Ltd.
Sun Pharmaceutical Industries Limited
Aurobindo Pharma Ltd.
Cipla Inc.
Hikma Pharmaceutical Plc
Apotex Inc.
Amneal Pharmaceutical Inc.
Lupin Ltd.
Zhejiang Huahai Pharmaceutical Co. Ltd.
Metrochem API Private Limited
Calyx Chemicals & Pharmaceuticals Limited
Farmhispania Group
Zydus Cadila Healthcare Ltd.
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병
제34장 최근의 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
리시노프릴 시장 2029 : 새로운 기회를 제공하는 국가
리시노프릴 시장 2029 : 새로운 기회를 제공하는 부문
리시노프릴 시장 2029 : 성장 전략
시장 동향에 기반한 전략
경쟁 전략
제36장 부록
KSM
영문 목차
영문목차
Lisinopril is a medication classified as an angiotensin-converting enzyme (ACE) inhibitor. It works by reducing certain chemicals that tighten blood vessels, facilitating smoother blood flow and improving the heart's pumping efficiency. Lisinopril is prescribed for adults to treat congestive heart failure and to increase survival rates after a heart attack.
The main brands of lisinopril include Zestoretic, Prinivil, Zestril, among others. Zestoretic is a combination medication containing lisinopril, an ACE inhibitor, and hydrochlorothiazide, a thiazide diuretic. It is used to treat conditions such as hypertension, heart failure, heart attacks, strokes, diabetic kidney disease, among others. It is available in various forms such as tablets and liquid, and is prescribed to different populations including children and adults. These medications are used by various end-users such as hospitals, specialty clinics, and others.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The lisinopril market research report is one of a series of new reports from The Business Research Company that provides lisinopril market statistics, including lisinopril industry global market size, regional shares, competitors with a lisinopril market share, detailed lisinopril market segments, market trends, and opportunities, and any further data you may need to thrive in the lisinopril industry. This lisinopril market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The lisinopril market size has grown strongly in recent years. It will grow from $1.76 billion in 2024 to $1.87 billion in 2025 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to increased accessibility, lifestyle shifts, increased screening programs, increased accessibility of generic lisinopril, and increased patient adherence.
The lisinopril market size is expected to see strong growth in the next few years. It will grow to $2.35 billion in 2029 at a compound annual growth rate (CAGR) of 5.9%. The growth in the forecast period can be attributed to rising prevalence of hypertension and cardiovascular diseases, generic versions and cost-effectiveness, growing awareness and early diagnosis, growing demand for effective treatments, and aging population. Major trends in the forecast period include innovations in drug delivery, need for enhanced and patient-centric drug delivery approaches, demand for cost-effective solutions, demand for effective treatments for heart failure, and demand for effective treatments for diabetic kidney disease.
The forecast of 5.9% growth over the next five years reflects a modest reduction of 0.4% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. healthcare systems by driving up the cost of Angiotensin-Converting Enzyme inhibitor(ACE) inhibitor medications and quality control testing equipment sourced from India and Puerto Rico, exacerbating hypertension treatment costs and creating medication access disparities. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The increasing prevalence of cardiovascular diseases is expected to drive the growth of the lisinopril market in the future. Cardiovascular diseases (CVDs) refer to a variety of conditions that affect the heart and blood vessels. The rising incidence of these diseases can be attributed to factors such as population growth, aging, risk factors, and the inadequate implementation of effective prevention and treatment strategies. Lisinopril aids in managing cardiovascular diseases primarily by lowering blood pressure and reducing the strain on the heart and kidneys. It works by inhibiting the production of angiotensin II, promoting blood vessel dilation, reducing blood volume, and protecting organs from damage. For example, in May 2024, the Singapore Heart Foundation (SHF), a non-profit organization based in Singapore, reported 5,302 deaths from ischemic heart diseases, a slight increase from 5,290 deaths in 2022. Therefore, the growing prevalence of cardiovascular diseases is fueling the growth of the lisinopril market.
The growing prevalence of hypertension is expected to boost the lisinopril market. Hypertension, or high blood pressure, is a condition where the force of blood against artery walls is consistently too high. Factors such as an unhealthy diet, sedentary lifestyle, aging population, and long-term stress contribute to the increasing prevalence of hypertension. Lisinopril effectively manages hypertension by blocking the formation of angiotensin II, leading to blood vessel relaxation, reduced blood volume, and lower blood pressure. For instance, the World Health Organization reported in March 2023 that around 1.28 billion adults aged 30-79 worldwide had hypertension. Therefore, the increasing prevalence of hypertension is driving the lisinopril market.
In January 2024, Sun Pharmaceutical Industries Limited, an Indian pharmaceutical company, acquired Taro Pharmaceutical Industries Ltd for $347.73 million. This acquisition allows Sun Pharma to expand its portfolio by incorporating Taro's expertise in generic and specialty medicines, active pharmaceutical ingredients (APIs), and over-the-counter products. Taro Pharmaceutical Industries Ltd, a US-based company, offers lisinopril.
North America was the largest region in the lisinopril market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lisinopril market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the lisinopril market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The lisinopril market consists of sales of prinivil, qbrelis, zestoretic, zestril and apo-lisinopril. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Lisinopril Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on lisinopril market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for lisinopril ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The lisinopril market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Brand: Zestoretic; Prinivil; Zestril; Other Brands
2) By Disease: Hypertension; Heart Failure; Heart Attack; Strokes; Diabetic Kidney Disease; Other Diseases
3) By Dosage: Tablet; Liquid; Other Dosages
4) By Population Type: Children; Adults
5) By End-Users: Hospitals; Specialty Clinics; Other End-Users
Subsegments:
1) By Zestoretic: Different Dosage Forms; Generic Versions Of Zestoretic
2) By Prinivil: Different Dosage Forms; Generic Versions Of Prinivil
3) By Zestril: Different Dosage Forms; Generic Versions Of Zestril
4) By Other Brands: International Brand Variants; Combination Drug Formulations
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Lisinopril Market Characteristics
3. Lisinopril Market Trends And Strategies
4. Lisinopril Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Lisinopril Growth Analysis And Strategic Analysis Framework
5.1. Global Lisinopril PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Lisinopril Market Growth Rate Analysis
5.4. Global Lisinopril Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Lisinopril Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Lisinopril Total Addressable Market (TAM)
6. Lisinopril Market Segmentation
6.1. Global Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Zestoretic
Prinivil
Zestril
Other Brands
6.2. Global Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hypertension
Heart Failure
Heart Attack
Strokes
Diabetic Kidney Disease
Other Diseases
6.3. Global Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Tablet
Liquid
Other Dosages
6.4. Global Lisinopril Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Children
Adults
6.5. Global Lisinopril Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Specialty Clinics
Other End-Users
6.6. Global Lisinopril Market, Sub-Segmentation Of Zestoretic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Different Dosage Forms
Generic Versions Of Zestoretic
6.7. Global Lisinopril Market, Sub-Segmentation Of Prinivil, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Different Dosage Forms
Generic Versions Of Prinivil
6.8. Global Lisinopril Market, Sub-Segmentation Of Zestril, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Different Dosage Forms
Generic Versions Of Zestril
6.9. Global Lisinopril Market, Sub-Segmentation Of Other Brands, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
International Brand Variants
Combination Drug Formulations
7. Lisinopril Market Regional And Country Analysis
7.1. Global Lisinopril Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Lisinopril Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Lisinopril Market
8.1. Asia-Pacific Lisinopril Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Lisinopril Market
9.1. China Lisinopril Market Overview
9.2. China Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Lisinopril Market
10.1. India Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Lisinopril Market
11.1. Japan Lisinopril Market Overview
11.2. Japan Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Lisinopril Market
12.1. Australia Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Lisinopril Market
13.1. Indonesia Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Lisinopril Market
14.1. South Korea Lisinopril Market Overview
14.2. South Korea Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Lisinopril Market
15.1. Western Europe Lisinopril Market Overview
15.2. Western Europe Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Lisinopril Market
16.1. UK Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Lisinopril Market
17.1. Germany Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Lisinopril Market
18.1. France Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Lisinopril Market
19.1. Italy Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Lisinopril Market
20.1. Spain Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Lisinopril Market
21.1. Eastern Europe Lisinopril Market Overview
21.2. Eastern Europe Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Lisinopril Market
22.1. Russia Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Lisinopril Market
23.1. North America Lisinopril Market Overview
23.2. North America Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Lisinopril Market
24.1. USA Lisinopril Market Overview
24.2. USA Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Lisinopril Market
25.1. Canada Lisinopril Market Overview
25.2. Canada Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Lisinopril Market
26.1. South America Lisinopril Market Overview
26.2. South America Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Lisinopril Market
27.1. Brazil Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Lisinopril Market
28.1. Middle East Lisinopril Market Overview
28.2. Middle East Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Lisinopril Market
29.1. Africa Lisinopril Market Overview
29.2. Africa Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Lisinopril Market Competitive Landscape And Company Profiles
30.1. Lisinopril Market Competitive Landscape
30.2. Lisinopril Market Company Profiles
30.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.4. AstraZeneca Plc Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Vitaris Inc. Overview, Products and Services, Strategy and Financial Analysis
31. Lisinopril Market Other Major And Innovative Companies
31.1. Teva Pharmaceutical Industries Limited
31.2. Bausch Health Companies Inc.
31.3. Hetero Ltd.
31.4. Sun Pharmaceutical Industries Limited
31.5. Aurobindo Pharma Ltd.
31.6. Cipla Inc.
31.7. Hikma Pharmaceutical Plc
31.8. Apotex Inc.
31.9. Amneal Pharmaceutical Inc.
31.10. Lupin Ltd.
31.11. Zhejiang Huahai Pharmaceutical Co. Ltd.
31.12. Metrochem API Private Limited
31.13. Calyx Chemicals & Pharmaceuticals Limited
31.14. Farmhispania Group
31.15. Zydus Cadila Healthcare Ltd.
32. Global Lisinopril Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Lisinopril Market
34. Recent Developments In The Lisinopril Market
35. Lisinopril Market High Potential Countries, Segments and Strategies
35.1 Lisinopril Market In 2029 - Countries Offering Most New Opportunities
35.2 Lisinopril Market In 2029 - Segments Offering Most New Opportunities
35.3 Lisinopril Market In 2029 - Growth Strategies
